New Insulin Dosing Software Approved for Pediatrics

New Insulin Dosing Software Approved for Pediatrics 

Glytec adds pediatric insulin dosing to its IV and subcutaneous use. Glytec’s Glucommander was the first insulin dosing software to be cleared for adult (ages 18+) intravenous use; it is the only company to achieve specific FDA clearance for subcutaneous use, and now it is the only company cleared to offer this technology to hospitals caring for children. Glytec’s clinician-developed, algorithm-based insulin-dosing software is a network based application designed to consider each patient’s insulin sensitivity to safely stabilize excursions while achieving and maintaining glucose levels within a clinician defined target range, allowing patients to achieve safe normoglycemia. This can translate to reductions in length of stay, infection rates, readmission rates, comorbidity, and even mortality.